SPDR S&P Pharmaceuticals ETF Shares Down 20.3% Since SmarTrend's Sell Call (XPH)
November 04, 2015 at 13:10 PM EST
SmarTrend identified a Downtrend for SPDR S&P Pharmaceuticals ETF (AMEX:XPH) on August 5th, 2015 at $64.44. In approximately 3 months, SPDR S&P Pharmaceuticals ETF has returned 20.34% as of...